Towards genomic drug therapy with antisense oligonucleotides

Annals of Medicine

Volumn 28, Issue 6, 1996, Pages 511-522

  Lönnberg, Harri ^a,c   Vuorio, Eero ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b Turku University   (Finland)

^c NONE   (Finland)

Author keywords

Antisense; DNA; Oligonucleotide; RNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; PEPTIDE NUCLEIC ACID;

BASE PAIRING; CHEMICAL STRUCTURE; DRUG UPTAKE; GENE THERAPY; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; TARGET CELL; VIRUS INFECTION;

EID: 0030474866     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999115     Document Type: Review

References (88)

1. Zamecnik PC, Stephenson ML. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 1978; 75: 280-4.
2. Green PJ, Pines O, Inouye M. The role of antisense RNA and gene regulation. Annu Rev Biochem 1986; 55: 569-97.
3. James W. Towards gene-inhibition therapy: a review of progress and prospects in the field of antiviral antisense nucleic acids and ribozymes. Antiviral Chem 1991; 2: 191-214.
4. Uhlmann E, Peyman A. Antisense oligonucleotides: a new therapeutic principle. Chem Rev 1990; 90: 543-84.
5. Thuong NT, Helene C. Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angew Chem Int Edn Engl 1993; 32: 666-90.
6. Helene C, Toulme J. Regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99-125.
7. Freier SM, Lima WF, Sanghvi YS, et al. Thermodynamics of antisense oligonucleotide hybridization. In: Erickson RP, Izant JG, eds. Gene Regulation: Biology of Antisense RNA and DNA. New York: Raven Press Ltd, 1992: 95-107.
8. Goodchild J. Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconjug Chem 1990; 1: 165-87.
9. English U, Gauss D. Chemically modified oligonucleotides as probes and inhibitors. Angew Chem Int Edn Engl 1991; 30: 613-29.
10. De Mesmaeker A, Häner R, Martin P, Moser HE. Antisense oligonucleotides. Acc Chem Res 1995; 28: 366-74.
11. Eckstein F. Nucleoside phosphorothioates. Annu Rev Biochem 1985; 54: 367-402.
12. Jager A, Levy MJ, Hecht SM. Oligonucleotide N-alkylphosphoramidates: synthesis and binding to polynucleotides. Biochemistry 1988; 27: 7237-46.
13. Miller PS, Yano J, Yano E, Carroll C, Jayaraman K, Ts'O POP. Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphonates. Biochemistry 1979; 18: 5134-43.
14. Miller PS, Fang KN, Kondo NS, Ts'O POP. Synthesis and properties of adenine and thymine nucleoside alkyl phosphotriesters, the neutral analogs of dinucleoside monophosphates. J Am Chem Soc 1971; 93: 6657-65.
15. Gryaznov S, Chen JK. Oligodeoxyribonucleotide N3′-P5′ phosphoramidates: synthesis and hybridization properties. J Am Chem Soc 1994; 116: 3143-4.
16. Gryaznov S, Skorski T, Cucco C, et al. Oligonucleotide N3′-P5′ phosphoroamidates as antisense agents. Nucleic Acids Res 1996; 24: 1508-14.
17. Maddry JA, Reynolds RC, Montgomery JA, Secrist JA III. Synthesis of nonionic oligonucleotide analogues. In: Sanghvi YS, Cook PD, eds. Carbohydrate Modifications in Antisense Research. ACS Symposium Series 580. Washington DC: American Chemical Society, 1994: 40-51.
18. Just G, Kawai SH. Synthesis and hybridization properties of DNA oligomers containing sulfide-linked dinucleosides. In: Sanghvi YS, Cook PD, eds. Carbohydrate Modifications In Antisense Research. ACS Symposium Series 580. Washington DC: American Chemical Society, 1994: 52-65.
19. Vasseur JJ, Debart F, Sanghvi YS, Cook PD. Synthesis of a novel methylhydroxylamine-linked nucleoside dinner and its incorporation into antisense sequences. J Am Chem Soc 1992; 114: 4006-7.
20. Jones RJ, Lin KY, Milligan, JF, Wadwani S, Matteucci MD. Synthesis and binding properties of pyrimidine oligodeoxynucleoside analogs containing neutral phosphodiester replacements: the formacetal and 3′-thioformacetal internucleoside linkages. J Org Chem 1993; 58: 2983-91.
21. Freier SM. Hybridization: consideration affecting antisense drugs. In: Crooke ST, Lebleu B, eds. Antisense Research and Applications. Boca Raton: CRC Press Inc., 1991: 67-82.
22. Lesnik EA, Guinosso CJ, Kawasaki AM, et al. Oligodeoxynucleotides containing 2′-O-modified adenosine: synthesis and effects on stability of DNA duplexes. Biochemistry 1993; 32: 7832-8.
23. Fisher TL, Terhorst T, Cao X, Wagner RW. Intracellular disposition and metabolism of fluorescently labelled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acid Res 1993; 21: 3857-65.
24. Cook PD. Medicinal chemistry of antisense oligonucleotides: future opportunities. Anticancer Drug Des 1991; 6: 585-607.
25. Imbach JL, Rayner B, Morvan F. Sugar-modified oligonucleotides: synthesis, physicochemical and biological properties. Nucleosides Nucleotides 1989; 8: 627-48.
26. Herdewijn P, De Winter H, Doboszewski B, et al. Hexopyranosyl-like oligonucleotides. In: Sanghvi YS, Cook PD, eds. Carbohydrate Modifications in Antisense Research. ACS Symposium series 580. Washington DC: American Chemical Society, 1994: 80-99.
27. Bellon L, Leudier C, Barascut JL, Maury G, Imbach JL. 4′-thio-RNA: a novel class of sugar modified β-RNA. In: Sanghvi YS, Cook PD, eds. Carbohydrate Modifications in Antisense Research. ACS Symposium series 580. Washington DC: American Chemical Society, 1994: 68-79.
28. Saha AK, Caulfield TJ, Hobbs C, Upson DA, Waychunas C, Yawman AM. 5′-Me-DNA. A new oligonucleotide analog: synthesis and biochemical properties. J Org Chem 1995; 60: 768-9.
29. Milligan JF, Matteucci MD, Martin JC. Current concepts in antisense drug design. J Med Chem 1993; 36: 1923-37.
30. Lin KY, Jones RJ, Matteucci M. Tricyclic 2′-deoxycytidine analogs: synthesis and incorporation into oligonucleotides which have enhanced binding to complementary RNA. J Am Chem Soc 1995; 117: 3873-4.
31. Agrawal S, Tang Y-C. GEM 91 - an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS. Antisense Res Dev 1992; 2: 261-6.
32. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333-5.
33. Gosh MK, Gosh K, Dahl O, Cohen JS. Evaluation of some properties of phosphorodithioate oligodeoxyribonucleotide for antisense application. Nucleic Acids Res 1993; 21: 5761-6.
34. Debart F, Rayner B, Degols G, Imbach JL. Synthesis and base-pairing properties of the nuclease resistant α-anomeric deoxyribonucleotide α-[r(UCUUAACCCACA)]. Nucleic Acids Res 1992; 20: 1193-200.
35. Wagner RW, Matteucci MD, Lewis JL, Gutierrez AJ, Moulds C, Froehler BC. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 1993; 260: 1510-3.
36. Boiziau C, Larrouy B, Sproat BS, Toulme JJ. Antisense 2′-O-alkyl oligoribonucleotides are efficient inhitors of reverse transcription. Nucleic Acids Res 1995; 23: 164-71.
37. Nielsen PE, Egholm M, Buchardt O. Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone. Bioconjug Chem 1994; 5: 3-7.
38. Hanvey JC, Peffer NC, Bisi JE, et al. Antisense and antigene properties of peptide nucleic acids. Science 1992; 258: 1481-5.
39. Knudsen M, Nielsen PE. Antisense properties of duplex-and triplex-forming PNAs. Nucleic Acids Res 1996; 24: 494-500.
40. De Mesmaeker A, Waldner A, Fritsch V, Lebreton J, Wolf RM. Synthetic modifications of antisense oligonucleotides: novel backbone replacements with improved properties. Bull Soc Chim Belg 1994; 103: 705-17.
41. Lima WF, Monia BP, Ecker DJ, Freier SM. Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry 1992; 31: 12055-61.
42. Vickers T, Baker BF, Cook PD, et al. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res 1991; 19: 3359-68.
43. Stull RA, Taylor LA, Szoka FC Jr. Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices. Nucleic Acids Res 1992; 20: 3501-8.
44. Francois JC, Thuong NT, Helene C. Recognition and cleavage of hairpin structures in nucleic acids by oligodeoxynucleotides. Nucleic Acids Res 1994; 22: 3943-50.
45. Cload ST, Schepartz A. Selection of structure-specific inhibitors of the HIV rev-rev response element complex. J Am Chem Soc 1994; 116: 437-42.
46. Giovannangeli C, Thuong NT, Helene C. Oligonucleotide clamps arrest DNA synthesis on a single stranded DNA target. Proc Natl Acad Sci USA 1993; 90: 10013-7.
47. Brossalina E, Pascolo E, Toulme JJ. The binding of an antisense oligonucleotide to a hairpin structure via triplex formation inhibits chemical and biological reactions. Nucleic Acids Res 1993; 21: 5616-22.
48. Francois JC, Helene C. Recognition and cleavage of single-stranded DNA containing hairpin structures by oligonucleotides forming both Watson-Crick and Hoogsteen hydrogen bonds. Biochemistry 1995; 34: 65-72.
49. Letsinger RL, Chatuvedi SK, Farooqui F, Salunkhe M. Use of hydrophobic substituents in controlling self assembly of oligonucleotides. J Am Chem Soc 1993; 115: 7535-6.
50. Beaucage SL, Iyer RP. The functionalization of oligonucleotides via phosphoramidite derivatives. Tetrahedron 1993; 49: 1925-63.
51. Yamana K, Nishijima Y, Ikeda T, et al. Synthesis and interactive properties of an oligonucleotide with anthraquinone at the sugar fragment. Bioconjug Chem 1990; 1: 319-24.
52. Lukhtanov EA, Kutyavin IV, Gamper HB, Meyer RB Jr. Oligodeoxyribonucleotides with conjugated dihydropyrroloindole oligopeptides: preparation and hybridization properties. Bioconjug Chem 1995; 6: 418-26.
53. Bonora GM, Biancotto G, Maffini M, Scremin CL. Large scale, liquid phase synthesis of oligonucleotides by the phosphoramidate approach. Nucleic Acids Res 1993; 21: 1213-21.
54. Citro G, Perrotti D, Cucco C, et al. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 1992; 89: 7031-5.
55. Manoharan M, Tivel KL, Cook PD. Lipidic nucleic acids. Tetrahedron Lett 1995; 36: 3651-4.
56. Stein CA, Ranajit P, DeVico AI, et al. Mode of action of 5′-linked cholesterol phosphorothioate oligonucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry 1991; 30: 2439-44.
57. Degols G, Leonetti JP, Benkirane M, Devaux C, LeBleu B. Poly (L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res Dev 1992; 2: 293-301.
58. Oberhauser B, Wagner E. Effective incorporation of 2′-O-methyl-oligoribonucleotides into liposomes and enhanced cell association through modification with thiocholesterol. Nucleic Acids Res 1992; 20: 533-8.
59. Svinarchuk FP, Konevetz DA, Pliasunova OA, Pokrovsky AG, Vlassov VV. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie 1993; 75: 49-54.
60. Iyer RP, Yu D, Agrawal S. Prodrugs of oligonucleotides: the acyloxy esters of oligodeoxyribonucleoside phosphorothioates. Bioorg Chem 1995; 23: 1-21.
61. Barber I, Rayner B, Imbach JL. The prooligonucleotide approach. I. Esterase-mediated reversibility of dithymidine S-alkyl-phosphorothiolates to dithymidine phosphorothioates. Bioorg Med Chem Lett 1995; 5: 563-8.
62. Leonetti JP, Machy P, Deglos G, Lebleu B, Laserman L. Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci USA 1990; 88: 2702-6.
63. Bonham MA, Brown S, Boyd AL, et al. An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res 1995; 23: 1197-203.
64. Metelev V, Liszienicz J, Agrawal S. Study of antisense oligonucleotide phosphorothioates containing segments of oligodeoxynucleotides and 2′-O-methyloligoribonucleotides. Bioorg Med Chem Lett 1994; 4: 2929-34.
65. Hoke GD, Draper K, Freier SM, et al. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res 1991; 19: 5743-8.
66. Christoffersen RE, Marr JJ. Ribozymes as human therapeutic agents. J Med Chem 1995; 38; 2023-37.
67. Butorin AS, Boiziau C, Le Doan T, Toulme JJ, Helene C. Effects of the terminal phosphate derivatization of β- and α-oligodeoxynucleotides on their antisense activity in protein biosynthesis, stability and uptake by eukaryotic cells. Biochimie 1992; 74: 485-9.
68. Pratviel G, Bernadou J, Meunier B. Carbon-hydrogen bonds of DNA sugar units as targets for chemical nucleases and drugs. Angew Chem Int Edn Engl 1995; 34: 746-69.
69. Hall J, Hüsken D, Pieles U, Moser HE, Häner R. Efficient sequence-specific cleavage of RNA using novel europium complexes conjugated to oligonucleotides. Chem Biol 1994; 1: 185-90.
70. Uchiyama Y, Inoue H, Ohtsuka E, et al. DNA-linked RNase H for site-selective cleavage of RNA. Bioconjug Chem 1994; 5: 327-32.
71. Felsenfeld G, Rich A. Formation of two- and three-stranded polyribonucleotides. Biochim Biophys Acta 1957; 26: 457-68.
72. Moser HE, Dervan PB. Sequence-specific cleavage of double helical DNA by triplet helix formation. Science 1987; 238: 645-50.
73. Xodo LE, Manzini G, Quadrifoglio F, Van der Marel GA, van Boom JH. Effect of 5′-methylcytosine on the stability of triplestranded DNA - a thermodynamic study. Nucleic Acids Res 1991; 19: 5625-31.
74. Priestley ES, Dervan PB. Sequence composition effects on the energetics of triple helix formation by oligonucleotides containing a designed mimic of protonated cytosine. J Am Chem Soc 1995; 117: 4761 -5.
75. Engholm M, Christensen L, Dueholm KL, Buchardt O, Coull J, Nielsen PE. Efficient pH-independent sequence-specific DNA binding by pseudoisocytosine-containing bis-PNA. Nucleic Acids Res 1995; 23; 217-22.
76. Beal PA, Dervan PB. Second structural motif for recognition of DNA by oligonucleotide directed triple-helix formation. Science 1991; 251: 1360-3.
77. Orson FM, Kinsey BM, McShan WM. Linkage structures strongly influence the binding cooperativity of DNA intercalators conjugated to triplex forming oligonucleotides. Nucleic Acids Res 1994; 22: 479-84.
78. Gryaznov SM, Lloyd DH. Modulation of oligonucleotide duplex and triplex stablity via hydrophobic interactions. Nucleic Acids Res 1993; 21: 5909-15.
79. Bolli M, Leumann C. Triple-helix formation of oligonucleotides containing [(3′S,5′R)-2′-deoxy-3′,5′-ethano-β-D- ribofuranosyl]nucleosides ('bicyclodeoxynucleosides'). Angew Chem Int Edn Engl 1995; 34: 694-6.
80. Porumb H, Dagneaux C, Letellier R, Malvy C, Taillandier E. Triple-helices targeted to the polypurine tract of a murine retrovirus. Gene 1994; 149: 101-7.
81. McDonald CD, Mahler LJ III. Recognition of duplex DNA by RNA polynucleotides. Nucleic Acids Res 1995; 23: 500-6.
82. Wang S, Kool ET. Relative stabilities of triple helices composed of combinations of DNA, RNA and 2′-O-methyl-RNA backbones: chimeric circular oligonucleotides as probes. Nucleic Acids Res 1995; 23; 1157-64.
83. Xodo L, Alunni-Fabbroni M, Manzini G, Quadrifoglio F. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition. Nucleic Acids Res 1994; 22: 3322-30.
84. Reynolds MA, Arnold LJ Jr, Almazan MT, et al. Triple-strand-forming methylphosphonate oligodeoxynucleotides targeted to mRNA efficiently block protein synthesis. Proc Natl Acad Sci USA 1994; 91: 12433-7.
85. Nielsen PE, Engholm M, Berg RM, Buchardt O. Sequence-specific inhibition of DNA restriction enzyme cleavage by PNA. Nucleic Acids Res 1993; 21: 197-200.
86. Nielsen PE, Engholm M, Buchardt O. Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand. Gene 1994; 149: 139-45.
87. Laren HJ, Nielsen PE. Transcription-mediated binding of peptide nucleic acid (PNA) to double-stranded DNA: sequence-specific suicide transcription. Nucleic Acids Res 1996; 24: 458-63.
88. Kandimalla ER, Agrawal S. Single-strand targeted triplex formation. Destabilization of guanine quadruplex structures by foldback triplex-forming oligonucleotides. Nucleic Acids Res 1995; 23: 1068-74.